Literature DB >> 16184593

Analysis of outcome of laparoscopic splenectomy for idiopathic thrombocytopenic purpura by platelet count.

A Keidar1, M Feldman, A Szold.   

Abstract

Laparoscopic splenectomy (LS) is now performed routinely in patients with idiopathic thrombocytopenic purpura (ITP) refractory to the medical treatment. Low preoperative platelet count was deemed to be a contraindication for a laparoscopic approach; however, there is no data reporting the outcome in those patients. We aimed to evaluate the influence of the preoperative platelet count on the operative and postoperative course and complication rate. Retrospective cohort study that was conducted in tertiary care university-affiliated medical center and included 110 consecutive patients who underwent LS. All patients were divided into three groups by their preoperative platelet counts: <or=20 x 10(9)/L (n = 12), (20-50) x 10(9)/L (n = 18), and >50 x 10(9)/L (n = 80). The outcome and the influence of preoperative factors predictive of complications, blood transfusion, and length of stay were compared between the groups. Patients with a platelet count of <or=20 x 10(9)/L had a much longer hospital stay, received more blood transfusions, and suffered more complications than patients with platelet counts of (20-50) x 10(9)/L or higher (P < 0.05). Transfused patients had a longer hospital stay than non-transfused patients (2.08 vs. 6.4 days, P = 0.029). The strongest predictor for transfusion was the platelet count (odds ratio = 23, P = 0.008). LS in patients with very low platelet counts is feasible and reasonably safe, but the platelet count is a major determinant of morbidity. Every effort should be made to elevate platelet levels to >20 x 10(9)/L before surgery. Patients with counts >20 x 10(9)/L can safely undergo LS. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 16184593     DOI: 10.1002/ajh.20433

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  12 in total

1.  Laparoscopic splenectomy for hematologic diseases: a preliminary analysis performed on the Italian Registry of Laparoscopic Surgery of the Spleen (IRLSS).

Authors:  M Casaccia; P Torelli; S Squarcia; M P Sormani; A Savelli; B Troilo; G Santori; U Valente
Journal:  Surg Endosc       Date:  2006-07-03       Impact factor: 4.584

Review 2.  [Adult autoimmune thrombocytopenia: diagnosis and treatment].

Authors:  Klaus Lechner; Ansgar Weltermann; Ingrid Pabinger
Journal:  Wien Klin Wochenschr       Date:  2006-05       Impact factor: 1.704

Review 3.  Laparoscopic splenectomy: standardized approach.

Authors:  Liane S Feldman
Journal:  World J Surg       Date:  2011-07       Impact factor: 3.352

Review 4.  Splenectomy for immune thrombocytopenia: down but not out.

Authors:  Shruti Chaturvedi; Donald M Arnold; Keith R McCrae
Journal:  Blood       Date:  2018-01-02       Impact factor: 22.113

5.  Laparoscopic Splenectomy for Immune Thrombocytopenic Purpura (ITP) Patients with Very Severe Thrombocytopenia.

Authors:  Shahana Gupta; Raja Kalayarasan; Sandip Chandrasekar; Senthil Gnanasekaran; Biju Pottakkat
Journal:  Indian J Hematol Blood Transfus       Date:  2017-11-25       Impact factor: 0.900

6.  Three-dimensional CT volumetry predicts outcome of laparoscopic splenectomy for splenomegaly: retrospective clinical study.

Authors:  Filippo Filicori; Cameron Stock; Andrew D Schweitzer; Xavier M Keutgen; Maria D Lagratta; Rasa Zarnegar; Thomas J Fahey
Journal:  World J Surg       Date:  2013-01       Impact factor: 3.352

7.  Laparoscopic versus open splenectomy for nontraumatic diseases.

Authors:  Christine F Maurus; Markus Schäfer; Markus K Müller; Pierre-Alain Clavien; Markus Weber
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

8.  Should we routinely transfuse platelet for immune thrombocytopenia patients with platelet count less than 10 × 10⁹/L who underwent laparoscopic splenectomy?

Authors:  Yunqiang Cai; Xubao Liu; Bing Peng
Journal:  World J Surg       Date:  2014-09       Impact factor: 3.352

Review 9.  Treatment Options for Primary Autoimmune Hemolytic Anemia: A Short Comprehensive Review.

Authors:  Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2015-08-10       Impact factor: 3.747

10.  Guideline on immune thrombocytopenia in adults: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Project guidelines: Associação Médica Brasileira - 2018.

Authors:  Margareth Castro Ozelo; Marina Pereira Colella; Erich Vinícius de Paula; Ana Clara Kneese Virgilio do Nascimento; Paula Ribeiro Villaça; Wanderley Marques Bernardo
Journal:  Hematol Transfus Cell Ther       Date:  2018-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.